查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1959159

全球臨床營養市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Clinical Nutrition Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 154 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

臨床營養市場預計將從 2025 年的 395.8 億美元成長到 2034 年的 666.4 億美元，2026 年至 2034 年的複合年成長率為 5.96%。

受慢性病日益增多以及人們對營養在醫療保健中重要性認知不斷提高的推動，臨床營養市場預計將迎來顯著成長。隨著醫療保健機構認知到營養在疾病預防和管理中的關鍵作用，包括特殊膳食補充劑、經腸營養和特殊醫學用途配方食品在內的臨床營養產品需求激增。這一趨勢反映了醫療模式向個人化醫療轉變的趨勢，即根據患者的特定需求量身定做營養方案，以改善治療效果和整體健康狀況。

此外，研發領域的進步正在重塑臨床營養學領域。持續的研究揭示了營養與各種健康狀況之間的聯繫，從而推動了針對特定患者需求的營養干預措施的發展。遠端醫療和行動醫療應用等數位健康技術的整合也加速了臨床營養服務的提供，使醫療專業人員能夠即時監測患者的進展並調整飲食指導。隨著市場的不斷發展，未來的重點將轉向開發能夠滿足患者和醫療服務提供者多樣化需求的創新臨床營養解決方案。

此外，預防醫學日益受到重視，這也對臨床營養市場產生了影響。隨著消費者越來越積極主動地關注自身健康，對能夠促進整體健康和預防疾病的營養產品的需求也日益成長。這種對預防的重視推動了研發投入，製造商致力於開發符合消費者日益成長的健康意識和保健需求的實證臨床營養產品。未來，臨床營養市場將以持續創新、對品質的承諾以及提供能夠改善患者照護和健康結果的有效營養解決方案為特徵。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

第4章 全球臨床營養市場：依產品分類

  • 市場分析、洞察與預測
  • 口腔臨床營養
  • 腸外營養
  • 經腸營養

第5章 全球臨床營養市場：依應用領域分類

  • 市場分析、洞察與預測
  • 阿茲海默症
  • 營養缺乏
  • 癌症治療
  • 糖尿病
  • 慢性腎臟病
  • 罕見疾病
  • 吞嚥困難
  • 疼痛管理
  • 吸收不良/消化系統疾病/腹瀉
  • 其他

第6章 全球臨床營養市場：依銷售管道分類

  • 市場分析、洞察與預測
  • 零售通路
  • 線上銷售管道
  • 機構銷售管道

第7章 全球臨床營養市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott Nutrition
    • Pfizer Inc
    • Bayer AG
    • Nestle
    • Baxter International Inc
    • Otsuka Holdings Co. Ltd
    • Mead Johnson & Company LLC
    • Danone（Nutricia）
    • Victus Inc
    • Fresenius Kabi
    • Meiji Holdings. Co. Ltd
    • Abbvie（Allergan）
    • Baxter
    • Grifols
    • SA
簡介目錄
Product Code: VMR112113875

The Clinical Nutrition Market size is expected to reach USD 66.64 Billion in 2034 from USD 39.58 Billion (2025) growing at a CAGR of 5.96% during 2026-2034.

The clinical nutrition market is poised for significant growth, driven by the increasing prevalence of chronic diseases and the rising awareness of the importance of nutrition in healthcare. As healthcare providers recognize the critical role of nutrition in disease prevention and management, the demand for clinical nutrition products, including specialized dietary supplements, enteral nutrition formulas, and medical foods, is surging. This trend reflects a broader shift towards personalized medicine, where nutrition is tailored to meet the specific needs of patients, enhancing treatment outcomes and overall health.

Moreover, advancements in research and technology are shaping the clinical nutrition landscape. Ongoing studies are uncovering the links between nutrition and various health conditions, leading to the development of targeted nutritional interventions that address specific patient needs. The integration of digital health technologies, such as telehealth and mobile health applications, is also facilitating the delivery of clinical nutrition services, allowing healthcare providers to monitor patient progress and adjust dietary recommendations in real-time. As the market continues to evolve, the focus will shift towards creating innovative clinical nutrition solutions that cater to the diverse needs of patients and healthcare providers.

Additionally, the increasing emphasis on preventive healthcare is influencing the clinical nutrition market. As consumers become more proactive about their health, the demand for nutritional products that support overall well-being and disease prevention is on the rise. This focus on prevention is driving investment in research and development, as manufacturers seek to create evidence-based clinical nutrition products that align with the growing consumer interest in health and wellness. The future of the clinical nutrition market will be characterized by continuous innovation, a commitment to quality, and a focus on delivering effective nutritional solutions that enhance patient care and health outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Oral Clinical Nutrition
  • Parenteral Nutrition
  • Enteral Feeding Formulas

By Application

  • Alzheimer's Disease
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others

By Sales Channel

  • Retail Sales Channels
  • Online Sales Channels
  • Institutional Sales Channels

COMPANIES PROFILED

  • Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc, Otsuka Holdings Co Ltd, Mead Johnson Company LLC, Danone Nutricia, Victus Inc, Fresenius Kabi, Meiji Holdings Co Ltd, Abbvie Allergan, Baxter, Grifols, SA

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CLINICAL NUTRITION MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Oral Clinical Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Parenteral Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Enteral Feeding Formulas Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CLINICAL NUTRITION MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Alzheimer's Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Nutrition Deficiency Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Cancer Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Chronic Kidney Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Orphan Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.8. Dysphagia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.9. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.10. Malabsorption/GI Disorder/Diarrhea Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CLINICAL NUTRITION MARKET: BY SALES CHANNEL 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Sales Channel
  • 6.2. Retail Sales Channels Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Online Sales Channels Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Institutional Sales Channels Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CLINICAL NUTRITION MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Application
    • 7.2.3 By Sales Channel
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Application
    • 7.3.3 By Sales Channel
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Application
    • 7.4.3 By Sales Channel
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Application
    • 7.5.3 By Sales Channel
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Application
    • 7.6.3 By Sales Channel
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CLINICAL NUTRITION INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Abbott Nutrition
    • 9.2.2 Pfizer Inc
    • 9.2.3 Bayer AG
    • 9.2.4 Nestle
    • 9.2.5 Baxter International Inc
    • 9.2.6 Otsuka Holdings Co. Ltd
    • 9.2.7 Mead Johnson & Company LLC
    • 9.2.8 Danone (Nutricia)
    • 9.2.9 Victus Inc
    • 9.2.10 Fresenius Kabi
    • 9.2.11 Meiji Holdings. Co. Ltd
    • 9.2.12 Abbvie (Allergan)
    • 9.2.13 Baxter
    • 9.2.14 Grifols
    • 9.2.15 S.A